MODURETIC 5-50 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Moduretic 5-50, and what generic alternatives are available?
Moduretic 5-50 is a drug marketed by Merck and is included in one NDA.
The generic ingredient in MODURETIC 5-50 is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Moduretic 5-50
A generic version of MODURETIC 5-50 was approved as amiloride hydrochloride; hydrochlorothiazide by BARR on May 10th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MODURETIC 5-50?
- What are the global sales for MODURETIC 5-50?
- What is Average Wholesale Price for MODURETIC 5-50?
Summary for MODURETIC 5-50
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 2 |
Patent Applications: | 114 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MODURETIC 5-50 at DailyMed |
![MODURETIC 5-50 drug patent expirations Drug patent expirations by year for MODURETIC 5-50](/p/graph/s/t/MODURETIC_5-50-patent-expirations.png)
Recent Clinical Trials for MODURETIC 5-50
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | Phase 1 |
Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
US Patents and Regulatory Information for MODURETIC 5-50
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | MODURETIC 5-50 | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 018201-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MODURETIC 5-50
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | MODURETIC 5-50 | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 018201-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MODURETIC 5-50
See the table below for patents covering MODURETIC 5-50 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 1050732 | ⤷ Sign Up | |
Germany | 1695491 | ⤷ Sign Up | |
Netherlands | 6400813 | ⤷ Sign Up | |
Norway | 123033 | ⤷ Sign Up | |
United Kingdom | 1050730 | ⤷ Sign Up | |
Denmark | 113501 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |